569 The Leuven PARPi benefit test as improved approach for prediction of PARPi benefit in the PAOLA-1/ENGOTov25 trial | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Oral Sessions

11. Translational research/biomarkers

569 The Leuven PARPi benefit test as improved approach for prediction of PARPi benefit in the PAOLA-1/ENGOTov25 trial

Online download statistics by month:

Online download statistics by month: March 2024 to December 2024

	Abstract	Full	Pdf
Mar 2024	173	0	8
Apr 2024	111	0	3
May 2024	44	0	3
Jun 2024	60	0	1
Jul 2024	46	0	2
Aug 2024	13	0	0
Sep 2024	74	0	1
Oct 2024	48	0	1
Nov 2024	25	0	1
Dec 2024	6	0	0
Total	600	0	20